osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
#asco23 #adaura 1st phiii study to translate dfs benefit of egfr tki to os 1 benefit seen for all stages ib-iiia and despite use of adj chemo- hr 0.49
2 response seen past tx discontinuation at 5yr
3 88% of placebo arm received tki at progression (only 43% osi) #lcsm 
Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed